Oligonucleotide Synthesis Market worth $37.41 billion by 2030, growing at a CAGR of 20.24% - Exclusive Report by 360iResearch

The "Oligonucleotide Synthesis Market by Product (Equipment, Linkers & Adaptor, Probes), Type (Custom, Pre-designed), Application, End-User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Oligonucleotide Synthesis Market to grow from USD 10.29 billion in 2023 to USD 37.41 billion by 2030, at a CAGR of 20.24%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/oligonucleotide-synthesis?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Oligonucleotide synthesis is a chemical process that involves the automated assembly of single-stranded DNA or RNA molecules, referred to as oligonucleotides. This process is used in various applications, including research and development, drug discovery, gene therapy, and forensic science. The rising prevalence of chronic diseases worldwide is resulting in increased drug discovery and research activities and is facilitating the use of the oligonucleotide synthesis process to develop efficient drugs and therapeutics. The increasing investments in pharmaceutical and biotechnology research are expanding the use of oligonucleotide synthesis processes to create custom nucleic acid sequences that can be used for targeted gene expression, diagnostic testing, and therapeutic agents. However, the high cost of production and issues in large-scale oligonucleotide synthesis may adversely impact the use of the oligonucleotide synthesis process by the end-use sectors. Moreover, the ongoing improvements and collaboration to expand the production of oligonucleotides are expected to encourage the use of the oligonucleotide synthesis processes by end-use industries worldwide.

The oligonucleotide synthesis market is evolving in the Americas owing to the presence of a well-established healthcare sector, increasing drug and therapeutic research activities, and a growing need for improved diagnostic testing solutions. The rising prevalence of chronic diseases, government initiatives and investments in modernizing healthcare infrastructure, and increasing drug discovery and research is facilitating the use of the oligo synthesis process across the end-use sectors in the region. The growing need for early and efficient disease diagnosis, expanding life-science and medical research, and growing focus on developing improved diagnostic solutions are accelerating the use of the oligonucleotide synthesis processes by the research institutes and diagnostic laboratories in the EMEA region. Additionally, the ongoing research to minimize errors and enhance the quality and efficiency of the oligonucleotide synthesis process is anticipated to propel the growth of the oligonucleotide synthesis market worldwide.

Market Segmentation & Coverage:

This research report categorizes the Oligonucleotide Synthesis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Equipment, Linkers & Adaptor, Probes, Reagents & Consumables, Services, and Synthesized Oligonucleotides. The Equipment is projected to witness significant market share during forecast period.

Based on Type, market is studied across Custom and Pre-designed. The Pre-designed is projected to witness significant market share during forecast period.

Based on Application, market is studied across Diagnostic, Research, and Therapeutic. The Diagnostic is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic Research Institutes, CROs & CMOs, Diagnostic Laboratories & Hospitals, and Pharmaceutical & Biotechnology Companies. The Diagnostic Laboratories & Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/oligonucleotide-synthesis?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Oligonucleotide Synthesis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Oligonucleotide Synthesis Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Oligonucleotide Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ajinomoto Bio-Pharma Services, ATDBio Ltd., Bio-synthesis Inc., Biocomma Ltd., Biolegio B.V., Biolytic Lab Performance Inc., Bioserve India by Reprocell Group, Bon Opus Biosciences, LLC, Creative Biogene, Cusabio Technology LLC, Danaher Corporation, Eurofins Genomics LLC, Eurogentec S.A. by Kaneka Corporation, GE Healthcare Inc., Generi Biotech, Genscript Corporation, Hongene Biotech Corp., LGC Genomics Limited, Merck KGaA, Microsynth AG, Nitto Denko Avecia Inc., Novartis AG, Perkin Elmer, SLS Research Pvt Ltd., Synbio Technologies, TAG Copenhagen A/S, TCI Chemicals (India) Pvt. Ltd., Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Oligonucleotide Synthesis Market, by Product
7. Oligonucleotide Synthesis Market, by Type
8. Oligonucleotide Synthesis Market, by Application
9. Oligonucleotide Synthesis Market, by End-User
10. Americas Oligonucleotide Synthesis Market
11. Asia-Pacific Oligonucleotide Synthesis Market
12. Europe, Middle East & Africa Oligonucleotide Synthesis Market
13. Competitive Landscape
14. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Oligonucleotide Synthesis Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Oligonucleotide Synthesis Market?
3. What is the competitive strategic window for opportunities in the Oligonucleotide Synthesis Market?
4. What are the technology trends and regulatory frameworks in the Oligonucleotide Synthesis Market?
5. What is the market share of the leading vendors in the Oligonucleotide Synthesis Market?
6. What modes and strategic moves are considered suitable for entering the Oligonucleotide Synthesis Market?

Read More @ https://www.360iresearch.com/library/intelligence/oligonucleotide-synthesis?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.